bioRxiv Science⌕ Search

Biology subjects

Bektas, E. I.

Publications and source records attributed to Bektas, E. I..

2 recordsLinked to original sources

Modulation of Neutrophil Function by Foetal Bovine Serum and Type I Collagen

Immune regulation plays a crucial role during the regeneration process, and it determines the fate of inflammation after tissue injury or infection. Neutrophils serve as the primary immune cells recruited to the site of inflammation, initiating and directing the subsequent inflammatory cascade following implantation. As neutrophils are highly sensitive to environmental cues, commonly used culture supplements and molecules may themselves influence neutrophil function and consequently affect the interpretation of biomaterial-induced immune responses. This study examined how foetal bovine serum (FBS), a standard in vitro culture supplement, affects human peripheral blood neutrophils when supplied either in the culture medium or as a surface coating on 3D-printed polycaprolactone (PCL) scaffolds. The response to type I collagen coating was also assessed as a biologically relevant comparator. Neutrophil activity was evaluated by assessing metabolic activity and metabolomic profiles, reactive oxygen species (ROS) production, and inflammation-related markers via a high-throughput proximity extension assay. Type I collagen coating modified the metabolomic profile of neutrophils and MMP-9 release but had minimal effect on ROS generation. In contrast, the presence of FBS in the culture medium significantly influenced neutrophil behavior, leading to significant changes in metabolic activity, cytotoxicity, and the secretion of inflammation-associated molecules, even at concentrations as low as 1% (v/v). These findings highlight the importance of assessing the use of FBS in neutrophil culture models, particularly those isolated from humans, and emphasize the need to develop alternative platforms for investigating neutrophil-biomaterial interactions in a more physiologically relevant manner.

immunology↗

Effect of molecular weight of tyramine-modified hyaluronan on polarization state of peripheral blood mononuclear cells-derived macrophages

The immunomodulatory properties of hyaluronan and its derivatives are key to their use in medicine and tissue engineering. In this work we evaluated the capability of soluble tyramine-modified hyaluronan (THA) of two molecular weights (low Mw=280 kDa and high Mw=1640 kDa) for polarization of THP-1 and peripheral blood mononuclear cells (PBMCs)-derived macrophages (M{Phi}s). We demonstrate the polarization effects of the supplemented THA by flow cytometry and multiplex ELISA for the THP-1 derived M{Phi}s and by semi-automated image analysis from confocal microscopy, immunofluorescent staining utilising CD68 and CD206 surface markers, RT-qPCR gene expression analysis, as well as using the enzyme-linked immunosorbent assay (ELISA) for PBMCs-derived M{Phi}s. Our data indicate that supplementation with LMW THA drives changes in THP-1 derived M{Phi}s towards a pro-inflammatory M1-like phenotype, whereas supplementation with the HMW THA leads to a more mixed profile with some features of both M1 and M2 phenotypes, suggesting either a heterogeneous population or a transitional state. For cells directly sourced from human patients, PMBCs-derived M{Phi}s, results exhibit a higher degree of variability, pointing out a differential regulation of factors including IL-10 and CD206 between the two cell sources. While human primary cells add to the clinical relevance, donor diversity introduces wider variability in the dataset, preventing drawing strong conclusions. Nevertheless, the M{Phi}s profiles observed in THP-1 derived cells for treatments with LMW and HMW THA are generally consistent with what might be expected for the treatment with non-modified hyaluronans of respective molecular weights, confirming the known association holds true for the chemically tyramine-modified hyaluronan. We stipulate that these responses will provide basis for more accurate in vivo representation and translational immunomodulatory guidance for the use of THA-based biomaterials to a wider biomaterials and tissue engineering communities. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=114 SRC="FIGDIR/small/575241v3_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@899d95org.highwire.dtl.DTLVardef@c8b80aorg.highwire.dtl.DTLVardef@1aad98dorg.highwire.dtl.DTLVardef@1b0ce60_HPS_FORMAT_FIGEXP M_FIG C_FIG

bioengineering↗